Reimbursement Newsletter

RJ Health provides insight into new drugs and devices, code price updates and more as it applies to medically covered drugs.

Specialty Drug Reimbursement Newsletter | July 2022

July

15

2022

RJ Health, an MMIT company, delivers industry standard specialty drug pricing, coding and reimbursement solutions to support payer and provider alignment.   

Every month, our team evaluates a variety of pricing and coding updates. In the July edition of the Specialty Drug Reimbursement Newsletter, we identified 52 drug code price changes this month, with 25 of them being price decreases. We have also identified drugs to be added or updated within our database. Preview some of these insights below:  

This month, during our review of the 3395 Reimbursement HCPCS/CPT® Codes in our system, we identified 52 Drug Codes that required a recalculation of their AWP Code Price.  Log in to www.ReimbursementCodes.com to view the pricing updates for these codes.  

90389 E0607 J1741 J7402 J9050 S0160
A2004 J0153 J2060 J7507 J9218 S0174
A2013 J0500 J2270 J7512 J9281
A4213 J0670 J2710 J7605 J9305
A4253 J0894 J2760 J7631 Q2041
B4150 J1040 J2795 J8520 Q2053
B4153 J1327 J3095 J8521 Q4251
B4157 J1460 J3475 J8610 Q9968
B4158 J1558 J3489 J9025 S0122
B4160 J1670 J7314 J9041 S0157

ReimbursementCodes was designed for organizations like yours to manage pricing, coding and clinical challenges related to specialty drugs. To gain access to this tool and view the rest of the insights we captured this month, visit our site or contact marketing@mmitnetwork.com. 

Featured
Emerging-Treatments-Offer-New-Hope-Alcohol-Use-Disorder

Emerging Treatments Offer New Hope for Alcohol Use Disorder

Key-Takeaways-Rare-Disease-Commercialization

Competitive ATTR Dynamics: Key Takeaways for Rare-Disease Commercialization

Alternative-Funding-Programs

Alternative Funding Programs: Short-Term Savings, Long-Term Consequences

Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch